A 2017 prospective cohort study found no direct relationship between AF and liver enzyme levels, suggesting that the onset of AF may be influenced by heart failure markers, such as N-terminal pro-brain natriuretic peptide (NT-proBNP) [24], rather than liver dysfunction. The gene discussed is NPPB; the disease is atrial fibrillation.